Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-06-05 00:00:00 ET · period of report 2025-06-03 · accession 0001415889-25-015796 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-05 | 2025-06-05 | KNSA | Malley Thomas | Dir | M - OptEx | — | +3,173 | 12.5K | +34% | — |
| D | 2025-06-05 | 2025-06-05 | KNSA | Malley Thomas | Dir | M - OptEx | $0.00 | -3,173 | 0 | -100% | $0 |
| DM | 2025-06-05 | 2025-06-03 | KNSA | Malley Thomas | Dir | A - Grant | $0.00 | +19.6K | 16.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Shares | 2025-06-05 | M | A | 3,173 | — | 12,546 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 2 | Derivative | Restricted Share Units | 2025-06-05 | M | D | 3,173 | $0.00 | 0 | D | — · — to — | 3,173 Class A Ordinary Shares | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F5) The RSUs vested in a single installment on June 5, 2025; there was no expiration date for the RSUs. |
| 3 | Derivative | Restricted Share Units | 2025-06-03 | A | A | 2,799 | $0.00 | 2,799 | D | — · — to — | 2,799 Class A Ordinary Shares | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F4) The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is June 3, 2025. |
| 4 | Derivative | Share Option | 2025-06-03 | A | A | 16,798 | $0.00 | 16,798 | D | $29.11 · — to 2035-06-02 | 16,798 Class A Ordinary Shares | (F3) The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant with the final installment vesting on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is June 3, 2025. |